Cambridge Cognition, Ltd., US Agent: Clementi Associates, Ltd.
United KingdomFDA applicant, unverified
- Devices
- 1
What Cambridge Cognition, Ltd., US Agent: Clementi Associates, Ltd. makes
Cambridge Cognition produces digital cognitive assessment tools, including the Cantab Mobile platform, which evaluates cognitive functions such as attention, memory, and executive function via mobile devices.
The company’s products are classified as Class II medical devices in the US and are listed under the FDA’s 510(k) pathway. The company is based in the United States.
Catalogue
Cantab Mobile Ref K161328
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Cambridge Cognition, Ltd., US Agent: Clementi Associates, Ltd. have in the registry?
The registry currently lists 1 device for Cambridge Cognition, Ltd., US Agent: Clementi Associates, Ltd.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Cambridge Cognition, Ltd., US Agent: Clementi Associates, Ltd.'s devices?
Among its 1 most recently registered device, Cambridge Cognition, Ltd., US Agent: Clementi Associates, Ltd. has devices listed in FDA 510(k) (1 device).
What risk classes do Cambridge Cognition, Ltd., US Agent: Clementi Associates, Ltd.'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Cambridge Cognition, Ltd., US Agent: Clementi Associates, Ltd.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Cambridge Cognition, Ltd., US Agent: Clementi Associates, Ltd. in the registry?
The most recently registered devices listed for Cambridge Cognition, Ltd., US Agent: Clementi Associates, Ltd. include Cantab Mobile.